BCNA News 17 Jun 2019
Webcast: Hormone-blocking therapy – is it worth it?
BCNA’s latest webcast on hormone-blocking therapy (also known as endocrine therapy) proved one of its most popular to date, attracting more than 1000 registrations.
BCNA CEO Kirsten Pilatti was joined by medical oncologist Dr Richard de Boer, Professor of Obstetrics and Gynaecology at University of Melbourne Martha Hickey and BCNA member Kate Keogh Murray.
Typically prescribed for women diagnosed with hormone receptor positive breast cancers, the therapy works to lowering the amount of oestrogen in the body by blocking oestrogen receptors on cancer cells. While the treatment has proven very effective in reducing the risk of recurrence (breast cancer coming back), it can also induce menopausal symptoms.
The webcast explored the challenges posed by those side effects and how to minimise any potential impact on quality of life. It included a number of questions from the participants.
You can view this webcast and others from our growing library here: https://www.bcna.org.au/understanding-breast-cancer/resources/webcasts/